BioDelivery Sciences International Inc (NASDAQ:BDSI)

2.10
Delayed Data
As of 2:48pm ET
 0.00 / 0.00%
Today’s Change
1.65
Today|||52-Week Range
3.60
-28.81%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$122.9M

Company Description

BioDelivery Sciences International, Inc. is a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Contact Information

BioDelivery Sciences International, Inc.
4131 ParkLake Avenue
Raleigh North Carolina 27612
P:(919) 582-9050
Investor Relations:

Employees

Shareholders

Other institutional30.61%
Mutual fund holders14.17%
Individual stakeholders11.89%

Top Executives

Scott M. PleshaPresident
Joseph LockhartSenior Vice President-Operations
Ernest R. de PaolantonioCFO, Principal Accounting Officer & Secretary
Paul BlakeSenior VP-Clinical Research & Regulatory Affairs
James D. DarnleyVP, General Counsel & Compliance Officer